Extending the translational science benefits model to implementation science for cancer prevention and control.

IF 2.1 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Journal of Clinical and Translational Science Pub Date : 2024-11-05 eCollection Date: 2024-01-01 DOI:10.1017/cts.2024.582
Karen M Emmons, Ross C Brownson, Douglas A Luke
{"title":"Extending the translational science benefits model to implementation science for cancer prevention and control.","authors":"Karen M Emmons, Ross C Brownson, Douglas A Luke","doi":"10.1017/cts.2024.582","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There is increasing pressure on the federal research budget and shifting public opinions about the value of the academic enterprise. We must develop and apply metrics that demonstrate the broad benefits of research for health and society. The Translational Science Benefits Model (TSBM) measures the impact of large-scale translational science initiatives, such as the National Cancer Institute's Cancer Moonshot. TSBM provides the scaffolding to illustrate how science has real-world health impacts. We propose an expansion of the TSBM to explicitly include implementation-focused outcomes.</p><p><strong>Methods: </strong>TSBM includes four categories of benefits, including (1) clinical and medical, (2) community and public health, (3) economic, and (4) policy and legislative. Implementation science outcomes serve as a precursor to the model's established domains of impact and can help to sharpen focus on the translational steps needed to achieve a broad range of impacts. We provide several examples of studies that illustrate these implementation outcomes and other clinical and community benefits.</p><p><strong>Conclusions: </strong>It is important to consider a broad range of scientific impacts and the conditions that are necessary to achieve them. The expansion of the TSBM to include implementation science outcomes may help to accelerate the cancer community's ability to achieve the goal of preventing 4 million cancer deaths by 2047.</p>","PeriodicalId":15529,"journal":{"name":"Journal of Clinical and Translational Science","volume":"8 1","pages":"e211"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11713433/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical and Translational Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/cts.2024.582","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: There is increasing pressure on the federal research budget and shifting public opinions about the value of the academic enterprise. We must develop and apply metrics that demonstrate the broad benefits of research for health and society. The Translational Science Benefits Model (TSBM) measures the impact of large-scale translational science initiatives, such as the National Cancer Institute's Cancer Moonshot. TSBM provides the scaffolding to illustrate how science has real-world health impacts. We propose an expansion of the TSBM to explicitly include implementation-focused outcomes.

Methods: TSBM includes four categories of benefits, including (1) clinical and medical, (2) community and public health, (3) economic, and (4) policy and legislative. Implementation science outcomes serve as a precursor to the model's established domains of impact and can help to sharpen focus on the translational steps needed to achieve a broad range of impacts. We provide several examples of studies that illustrate these implementation outcomes and other clinical and community benefits.

Conclusions: It is important to consider a broad range of scientific impacts and the conditions that are necessary to achieve them. The expansion of the TSBM to include implementation science outcomes may help to accelerate the cancer community's ability to achieve the goal of preventing 4 million cancer deaths by 2047.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
推广转化科学效益模式,实施癌症防治科学。
联邦研究预算的压力越来越大,公众对学术事业价值的看法也在不断变化。我们必须制定和应用指标,证明研究对健康和社会的广泛益处。转化科学效益模型(TSBM)衡量大规模转化科学计划的影响,例如国家癌症研究所的癌症登月计划。TSBM提供了脚手架来说明科学如何对现实世界的健康产生影响。我们建议扩大TSBM,明确包括以实施为重点的成果。方法:TSBM包括四大类效益,包括(1)临床和医疗效益,(2)社区和公共卫生效益,(3)经济效益,(4)政策和立法效益。实施科学成果是该模型已确定的影响领域的先驱者,可以帮助重点关注实现广泛影响所需的转化步骤。我们提供了几个研究实例来说明这些实施结果和其他临床和社区效益。结论:重要的是要考虑广泛的科学影响和实现这些影响所需的条件。将TSBM扩大到包括实施科学成果,可能有助于加快癌症界实现到2047年预防400万癌症死亡的目标的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Clinical and Translational Science
Journal of Clinical and Translational Science MEDICINE, RESEARCH & EXPERIMENTAL-
CiteScore
2.80
自引率
26.90%
发文量
437
审稿时长
18 weeks
期刊最新文献
Health impacts of a remotely delivered prolonged nightly fasting intervention in stressed adults with memory decline and obesity: A nationwide randomized controlled pilot trial - ADDENDUM. Erratum: 489 Nasal-derived Extracellular Vesicles (EVs) carry a cargo of antiviral and immunomodulatory molecules - CORRIGENDUM. Local context review by single institutional review boards: Results from a modified Delphi process. Considerations and recommendations for collaborative research networks in epidemiology: Lessons learned from the diabetes LEAD Network. Training T-shaped translational scientists.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1